World

400 days of Israeli genocidal war on Gaza Strip

Nov 11, 2024

Gaza [Palestine], November 11: The Israeli genocidal war on the besieged Gaza Strip completed 400 days on Saturday, November 9, and there are still no signs of the murderous aggression ending or slowing down.
From dead bodies lying scattered on the streets to hospitals and schools razed down to children orphaned and millions rendered homeless, the gory events unfolding in the coastal Palestinian territory represent a textbook case of genocide and ethnic cleansing, according to experts.
The death toll in the territory since the Israeli regime launched its indiscriminate aerial and ground assault exactly 400 days ago, on October 7, 2023, has surpassed 43,500, most of them children and women.
Almost all medical facilities in the territory have become defunct due to infrastructure damages as well as the lack of electricity and fuel to keep the essential services running.
There are no "safe zones" anymore and people are either putting up in makeshift shelters or refugee camps in both the northern and southern Gaza Strip, which are frequently exposed to Israeli attacks.
Source: Qatar Tribune

More news

Concept Medical Announces Successful SIRONA Trial Results, Demonstrating Sirolimus-Coated Balloon as a Promising Alternative for PAD Treatment

Tampa (Florida) [US], January 7: Concept Medical Inc., a global leader in innovative drug-delivery technology, proudly reports positive outcomes from the SIRONA (Head-to-Head Comparison of SIROlimus versus Paclitaxel Drug-Eluting BallooNAngioplasty in the Femoropopliteal Artery) RCT, which show that its sirolimus-coated balloons (SCB) (MagicTouch -PTA) provide patency and functional benefits on par with paclitaxel-coated balloons for patients suffering from peripheral artery disease (PAD). The 1-year data was presented by Principal Investigator Prof. Ulf Teichgraber at the TCT USA 2024 conference in a Late-Breaking Clinical Trials Session (LBCT). Coverage by TCTMD has highlighted these findings, underscoring sirolimus-based therapy as a viable new option in femoropopliteal interventions.

Jan 07, 2025